CBPP Spotlight Live February 2021 | Case-Based Peer Perspectives Spotlight Live

CBBP: Feb. 21

Experts Compare Available Regimens for a Patient With Sarcomatoid Features

March 02, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspective virtual event, Amir Mortazavi, MD andMoshe Ornstein, MD, MA discussed available treatment regimen for a patient with clear cell renal cell carcinoma and sarcomatoid features.

Historical and Current Data Inform the Ovarian Treatment Landscape for Practicing Oncologists

February 21, 2021

Clinical Articles

Gynecologic oncology relies on both historical and modern therapies for the treatment of patients with ovarian cancer. During a Targeted Oncology Case-Based Peer Perspective virtual event, Michael J. Birrer, MD, PhD, reviewed the data.

Park Discusses Targeted Therapy Trials in Intermediate- and High-Risk ccRCC

February 21, 2021

Clinical Articles

In a 7 to 1 vote, oncologists favored the use of axitinib in combination with pembrolizumab or avelumab over cabozantinib monotherapy for the treatment of intermediate and high-risk clear cell renal cell carcinoma. Chandler H. Park, MD, reviewed that clinical trial research that supports the axitinib combinations, as well as other targeted therapy options.

Bekaii-Saab Explores Chemotherapies and Targeted Treatment Options in Metastatic CRC

February 03, 2021

Clinical Articles

During a virtual Targeted Oncology Case-Based Peer Perspectives event, Dr. Tanios Bekaii-Saab discussed the chemotherapy and targeted treatment options available for the treatment of patients with metastatic colorectal cancer with participating oncologists.